Balfour Beatty plc (LON:BBY – Get Free Report) reached a new 52-week high during mid-day trading on Thursday following insider buying activity. The company traded as high as GBX 439.80 ($5.81) and last traded at GBX 439.80 ($5.81), with a volume of 381073 shares traded. The stock had previously closed at GBX 429.60 ($5.68).
Specifically, insider Robert MacLeod bought 17,674 shares of Balfour Beatty stock in a transaction dated Tuesday, September 17th. The stock was bought at an average cost of GBX 422 ($5.57) per share, for a total transaction of £74,584.28 ($98,526.13).
Analyst Ratings Changes
Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 475 ($6.27) target price on shares of Balfour Beatty in a research report on Thursday, August 15th.
Balfour Beatty Trading Up 1.6 %
The firm has a 50-day moving average of GBX 412.10 and a two-hundred day moving average of GBX 384.10. The firm has a market capitalization of £2.23 billion, a P/E ratio of 1,039.52, a P/E/G ratio of 3.75 and a beta of 0.81. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 79.17.
Balfour Beatty Cuts Dividend
The business also recently announced a dividend, which will be paid on Friday, December 6th. Shareholders of record on Thursday, October 31st will be given a GBX 3.80 ($0.05) dividend. The ex-dividend date is Thursday, October 31st. This represents a yield of 0.93%. Balfour Beatty’s dividend payout ratio is currently 2,857.14%.
Balfour Beatty Company Profile
Balfour Beatty plc finances, designs, develops, builds, and maintains infrastructure in the United Kingdom, the United States, and internationally. It operates through three segments: Construction Services, Support Services, and Infrastructure Investments. The company constructs buildings, including commercial, healthcare, education, retail, and residential assets; and infrastructure assets comprising highways and railways, as well as other large-scale infrastructure assets, such as waste, water, and energy plants.
Featured Articles
- Five stocks we like better than Balfour Beatty
- Breakout Stocks: What They Are and How to Identify Them
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- What Investors Need to Know About Upcoming IPOs
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- 3 Stocks to Consider Buying in October
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Balfour Beatty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balfour Beatty and related companies with MarketBeat.com's FREE daily email newsletter.